Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy

Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy

Abstract Background To evaluate spot-scanning proton arc therapy (SPArc) and multi-field robust optimized intensity modulated proton therapy (RO-IMPT) in treating stage III non-small-cell lung cancer (NSCLC) patients. Methods Two groups of stage IIIA or IIIB NSCLC patients (group 1: eight patients w...

Full description

Bibliographic Details
Main Authors: Xiaoqiang Li, Peyman Kabolizadeh, Di Yan, An Qin, Jun Zhou, Ye Hong, Thomas Guerrero, Inga Grills, Craig Stevens, Xuanfeng Ding
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Radiation Oncology
Subjects:
Spot scanning
Proton arc therapy
Lung cancer
Robust treatment planning
Online Access:http://link.springer.com/article/10.1186/s13014-018-0981-6

Internet

http://link.springer.com/article/10.1186/s13014-018-0981-6

Similar Items